Varlilumab: A Deep Dive into CDX-1127 and its Mechanism Varlilumab (formerly known as PRT-052) represents a novel therapeutic agent targeting CD27. The drug's mechanism relies on association to this CD27 protein, a https://gorillasocialwork.com/story27153496/text